Cargando…
Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs
Autores principales: | Ferhat, Maroua, Hablot, Julie, Taieb, Mahdia, Salem, Fatouma, Netter, Patrick, Peyrin‐Biroulet, Laurent, Jouzeau, Jean‐Yves, Moulin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236119/ https://www.ncbi.nlm.nih.gov/pubmed/34185413 http://dx.doi.org/10.1002/ctm2.455 |
Ejemplares similares
-
Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis
por: Hablot, Julie, et al.
Publicado: (2020) -
Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice
por: Hablot, Julie, et al.
Publicado: (2017) -
Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis
por: Lebre, Maria C., et al.
Publicado: (2011) -
Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4(+) Treg in nonhuman primates
por: Wang, Zhaohui, et al.
Publicado: (2018) -
The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)